Insulet News - August 5, 2026
🔴 Insulet is trading 23% down today as 2026 sales guidance cut offsets Q2 beat
Insulet is trading 23% down at $131.65 after its second-quarter earnings release showed strong revenue and EPS beats but a cut to full-year 2026 sales...
🔴 Insulet is trading 10.1% down today on lowered FY26 sales outlook and Omnipod guidance
Insulet is trading 10.1% down at $149.98 after the company lowered its long-term sales outlook despite beating Q2 earnings expectations. • The company cut its...
Insulet's second quarter revenue grew 23.5% to beat estimates, but the company lowered its full-year 2026 sales forecast.
Insulet reported second quarter revenue of $801.7 million, up 23.5% year-over-year, and adjusted EPS of $1.66. These results surpassed analyst expectations for...